{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:56:46Z","timestamp":1790708206973,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["204725-3"],"award-info":[{"award-number":["204725-3"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012446","name":"Akershus Universitetssykehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015031","name":"Senter for rus- og avhengighetsforskning, Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cct.2025.107861","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:32:05Z","timestamp":1740137525000},"page":"107861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Changes in mental health during long-term treatment with extended-release naltrexone: A 3-year clinical study of opioid dependent individuals"],"prefix":"10.1016","volume":"152","author":[{"given":"Kristin Klemmetsby","family":"Solli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u016brat\u0117 \u0160altyt\u0117","family":"Benth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn Camilla Wergeland","family":"Digranes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Holtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj","family":"Kunoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Tanum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cct.2025.107861_bb0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.5664\/jcsm.9676","article-title":"Worsening sleep quality across the lifespan and persistent sleep disturbances in persons with opioid use disorder","volume":"18","author":"Ellis","year":"2022","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.cct.2025.107861_bb0010","doi-asserted-by":"crossref","first-page":"109551","DOI":"10.1016\/j.drugalcdep.2022.109551","article-title":"Prevalence of mental disorders among people with opioid use disorder: a systematic review and meta-analysis","volume":"238","author":"Santo","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.cct.2025.107861_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6\u20137","key":"10.1016\/j.cct.2025.107861_bb0020","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.addbeh.2009.01.002","article-title":"Gender and comorbidity among individuals with opioid use disorders in the NESARC study","volume":"34","author":"Grella","year":"2009","journal-title":"Addict. Behav."},{"issue":"6\u20137","key":"10.1016\/j.cct.2025.107861_bb0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.addbeh.2009.03.010","article-title":"Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base","volume":"34","author":"Hall","year":"2009","journal-title":"Addict. Behav."},{"key":"10.1016\/j.cct.2025.107861_bb0030","author":"WHO"},{"issue":"5","key":"10.1016\/j.cct.2025.107861_bb0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J. Clin. Sleep Med."},{"issue":"10","key":"10.1016\/j.cct.2025.107861_bb0040","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1080\/10826084.2018.1552298","article-title":"Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment","volume":"54","author":"Hallinan","year":"2019","journal-title":"Subst. Use Misuse"},{"issue":"1","key":"10.1016\/j.cct.2025.107861_bb0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13011-017-0101-x","article-title":"Sleep disturbance and its associations with severity of dependence, depression and quality of life among heroin-dependent patients: a cross-sectional descriptive study","volume":"12","author":"Chen","year":"2017","journal-title":"Subst Abuse Treat. Prev. Policy."},{"issue":"10","key":"10.1016\/j.cct.2025.107861_bb0050","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopsych.2004.06.037","article-title":"Treatment of depression in patients with opiate dependence","volume":"56","author":"Nunes","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cct.2025.107861_bb0055","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Association AP","year":"1994"},{"key":"10.1016\/j.cct.2025.107861_bb0060","author":"WHO"},{"issue":"3","key":"10.1016\/j.cct.2025.107861_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J. Addict. Dis."},{"issue":"2","key":"10.1016\/j.cct.2025.107861_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harv. Rev. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2025.107861_bb0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12955-020-01599-3","article-title":"The effect of methadone on depression among addicts: a systematic review and meta-analysis","volume":"18","author":"Mohammadi","year":"2020","journal-title":"Health Qual. Life Outcomes"},{"issue":"1","key":"10.1016\/j.cct.2025.107861_bb0080","first-page":"55","article-title":"Compliance with buprenorphine medication-assisted treatment and relapse to opioid use","volume":"21","author":"Tkacz","year":"2012","journal-title":"Am. J. Addict.\/Am. Acad. Psychiat. Alcohol. Addict."},{"issue":"14","key":"10.1016\/j.cct.2025.107861_bb0085","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1080\/10826084.2016.1201117","article-title":"Acceptability of extended-release naltrexone by heroin-dependent patients and addiction treatment providers in the Netherlands","volume":"51","author":"Zaaijer","year":"2016","journal-title":"Subst. Use Misuse"},{"issue":"3","key":"10.1016\/j.cct.2025.107861_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.drugpo.2010.09.007","article-title":"What is the role of harm reduction when drug users say they want abstinence?","volume":"22","author":"Neale","year":"2011","journal-title":"Int. J. Drug Policy"},{"issue":"6","key":"10.1016\/j.cct.2025.107861_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000346674","article-title":"The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review","volume":"19","author":"Notley","year":"2013","journal-title":"Eur. Addict. Res."},{"issue":"12","key":"10.1016\/j.cct.2025.107861_bb0100","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jamapsychiatry.2017.3206","article-title":"Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: a randomized clinical noninferiority trial","volume":"74","author":"Tanum","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"9776","key":"10.1016\/j.cct.2025.107861_bb0105","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cct.2025.107861_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-006-0509-x","article-title":"Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin","volume":"189","author":"Sullivan","year":"2006","journal-title":"Psychopharmacol"},{"issue":"4","key":"10.1016\/j.cct.2025.107861_bb0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/YCO.0000000000000510","article-title":"Treatment of substance use disorders with co-occurring severe mental health disorders","volume":"32","author":"Murthy","year":"2019","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2025.107861_bb0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/00952990.2010.540281","article-title":"The association between naltrexone treatment and symptoms of depression in opioid-dependent patients","volume":"37","author":"Mysels","year":"2011","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.cct.2025.107861_bb0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1139\/jpn.0605","article-title":"Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence","volume":"31","author":"Dean","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.cct.2025.107861_bb0130","first-page":"151","article-title":"Naltrexone and dysphoria: fact or myth?","volume":"11","author":"Miotto","year":"2002","journal-title":"Am. J. Addict.\/Am. Acad. Psychiat. Alcohol. Addict."},{"key":"10.1016\/j.cct.2025.107861_bb0135","article-title":"Anxiety, depression, and insomnia among adults with opioid dependence treated with extended-release naltrexone vs buprenorphine-naloxone: a randomized clinical trial and follow-up study","author":"Latif","year":"2018","journal-title":"JAMA Psychiatry."},{"issue":"5","key":"10.1016\/j.cct.2025.107861_bb0140","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/00952990.2016.1197231","article-title":"Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant","volume":"42","author":"Krupitsky","year":"2016","journal-title":"Am. J. Drug Alcoh. Abuse"},{"issue":"3","key":"10.1016\/j.cct.2025.107861_bb0145","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14140","article-title":"Co-occurring depression and suicidal ideation in opioid use disorder: prevalence and response during treatment with buprenorphine-naloxone and injection naltrexone","volume":"83","author":"Na","year":"2022","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.cct.2025.107861_bb0150","first-page":"291","article-title":"Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial","volume":"32","author":"Vest","year":"2023","journal-title":"Am. J. Addict.\/Am. Acad. Psychiat. Alcohol. Addict."},{"key":"10.1016\/j.cct.2025.107861_bb0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jad.2021.10.018","article-title":"Longitudinal study of impact of medication for opioid use disorder on Hamilton depression rating scale","volume":"297","author":"Wang","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.cct.2025.107861_bb0160","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/add.14278","article-title":"Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a nine-month follow-up to a three-month randomized trial","volume":"113","author":"Solli","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2025.107861_bb0165","article-title":"Adapting treatment length to opioid-dependent individuals\u2019 needs and preferences: a 2-year follow-up to a 1-year study of extended-release naltrexone","author":"Solli","year":"2020","journal-title":"Addiction"},{"issue":"Suppl. 20","key":"10.1016\/j.cct.2025.107861_bb0170","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2025.107861_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-016-0061-1","article-title":"Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)","volume":"17","author":"Kun\u00f8e","year":"2016","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.cct.2025.107861_bb0180","first-page":"208","article-title":"EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence","volume":"1","author":"Kokkevi","year":"1995","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.cct.2025.107861_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bs.3830190102","article-title":"The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory","volume":"19","author":"Derogatis","year":"1974","journal-title":"Behav. Sci."},{"issue":"7","key":"10.1016\/j.cct.2025.107861_bb0190","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s001270050064","article-title":"Concordance between symptom screening and diagnostic procedure: the Hopkins symptom Checklist-25 and the composite international diagnostic interview I","volume":"33","author":"Sandanger","year":"1998","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"4","key":"10.1016\/j.cct.2025.107861_bb0195","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the insomnia severity index as an outcome measure for insomnia research","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Med."},{"key":"10.1016\/j.cct.2025.107861_bb0200","author":"WMA"},{"key":"10.1016\/j.cct.2025.107861_bb0205","article-title":"No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: a 3-month randomized study and 9-month open-treatment follow-up study","author":"Z-e-H","year":"2019","journal-title":"Am. J. Addict.\/Am. Acad. Psychiat. Alcohol. Addict."},{"issue":"6","key":"10.1016\/j.cct.2025.107861_bb0210","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000501931","article-title":"Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: extension of a randomized clinical trial","volume":"25","author":"Solli","year":"2019","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.cct.2025.107861_bb0215","doi-asserted-by":"crossref","unstructured":"Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960;23(1):56\u201362. Epub 1960\/02\/01. doi: https:\/\/doi.org\/10.1136\/jnnp.23.1.56. PubMed PMID: 14399272; PubMed Central PMCID: PMCPMC495331.","DOI":"10.1136\/jnnp.23.1.56"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714425000552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714425000552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:29:24Z","timestamp":1777793364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714425000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":43,"alternative-id":["S1551714425000552"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2025.107861","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in mental health during long-term treatment with extended-release naltrexone: A 3-year clinical study of opioid dependent individuals","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2025.107861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107861"}}